edited drugs for repro_endo - Sheet1 Flashcards
amiloride
blocks Na channels -> decr MC effects in hyperaldosteronism *weaker effect than spirolactone
spironolactone: action, use and dosage (3 doses for 6 diseases)
antagonist at MC receptors (also androgen and progesterone receptors); 25-50 mg daily as K sparing diuretic for HTN and edematous states (CHF, cirrhosis, nephoris); 400 mg daily in primary hyperaldosteronism; 200 mg daily in PCOS (used off label for anti-androgen effects)
spironolactone side effects (4)
hyperkalemia, volume depletion, men: gynecomastia, impaired libido, impotence; women: mest. irregularities
eplerenone
highly selective (and expensive) MC antagonist (not androgens nor progesterone)
contraindications for spironolactone (3)
renal impairment, hyperkalemia, pregnancy
metyrapone
blocks 11-beta enzyme that converts 11-DOC -> cortisol; doesn’t interfere with aldosterone or androgen production (dx adrenal insufficiency as primary or central by seeing relative ACTH/11-DOC levels)
hydrocortisone dosing
physiological: 20-30 mg/day in the am; stress: 50 mg every 6-8 hrs; acute: 100 mg IV/IM every 6-8 hrs (don’t need MC replacement b/c hydrocortisone works as MC above 100 mg)
dex dosing
physiological: .5 mg daily; stress: 2 mg every 12 hrs; acute: 4 mg IV/IM
ketoconazole
non-specific inhibitor of cortisol synthesis (inhibits at 3 steps)
cabergoline
DA agonist used to tx somatotroph adenoma -> paradoxical effect
octreotide
STT analog used to tx somatotroph or thyrotroph adenoma
pegvisomant
GH anatagonist used to tx somatotroph adenoma -> binds only 1/2 receptor and thus blocks it
metformin: action, MOA, effect, metab, adverse effects (4), benefits (3), contraindications (5), misc (1)
prevents gluconeogenesis (and poss glycogenolysis); phosphorylation (activation) of AMPK; improves fasting glucose (little effect on postprandial); not metabolized, renally excreted unchanged (can accum. if renal insuff); adverse: anorexia, nausea, diarrhea, lactic acidosis; benefits: immed onset (altho need to titrate slowly to avoid GI effects), no hypoglycemia, weight neutral (poss loss) -> first drug of choice; contraindications: prone to acidosis, hypoxic states, renal failure, cardiac ischemia, T1DM; need insulin to work!
TZDs: action, MOA, effect, duration/onset, contraindications (3), adverse effects (3), benefits (3)
incr. periph tissue sensitivity to insulin; binds to nuclear PPAR-gamma receptor (incr. GLUT4 transcription); lowers fasting and post-meal glucose; slow onset of action (fasting gluc begins to decr w/in 5-7 days but doesn’t completely decline until 2-3 mons); contraindications: liver disease, heart failure, renal insuff.; side effects: weight gain (improved glyc. control and incr water due to Na reabs), hepatocellular injury, incr LDL; benefits: reduces TGs, raises HDL, no hypoglycemia
secretagogues: types (2), differences
sulfonylurea and meglitinides; both bind the beta cell ATP-dep K channel but meglitinide binds more quickly and dissociates more quickly (shorter duration -> 3-4 hrs vs 12-24)
sulfonylurea: action, MOA, duration, effect, metab, contraindications (3), adverse effects (3)
secretagogue; binds to sulfonyl receptor in beta cell causing depolarization of ATP-dependent K channels; 12-24 hrs duration; effect on fasting glucose; metab: excreted via kidney w/ active metabs (careful w/ renal probs); contraind: T1DM, DKA, sulfa allergy; adverse effects: hypoglycemia, weight gain, hunger
meglitinides: action, MOA, duration and onset, metab, contraindications (4), adverse effects (2), aka
secretagogue; binds to sulfonyl receptor in beta cell causing depolarization of ATP-dependent K channels; 3-4 hrs duration w/ fast onset (give w/ every meal -> hard for compliance); metab: hepatic (P450) w/ most metabs excreted GI; contraind: T1DM, liver failure, DKA, sulfa allergy; adverse effects: low glucose 2-4 hrs after meal, weight gain; aka glinides
alpha-glucoside inhibitors: MOA, effects, side effects (2), contraindications (1), metab
delay carbohydrate absorption (inhibits intestinal enzymes ability to break down sugars) and thus incr GLP-1; effects postprandial glucose only; side effects: flatulence, bloating -> titrate slowly to minimize; contraindications: GI disorders (esp IBD); metab: renally excreted unchanged
GLP-1 mimetic: names (2), comparison, contraindications (2), effect, metab, benefits (2), side effects (1)
exenatide (from Gila monster) and liraglutide; liraglutide is once daily injection b/c binds albumin vs. exenatide is twice daily (60 mins before each meal); avoid in pts with severe GI disease or on drugs that need rapid GI abs; effect on postprandial glucose; metab: renal after DPP-4 breakdown; benefit: weight loss, no hypoglycemia; side effects: GI
biguanides: names (1)
metformin
incretin enhancers: MOA, duration, effect, metab, contraind, adverse effects, benefits (2)
DPP-4 inhibitors; 80% inhib at 24 hrs (take 1 daily); immed effect on postprandial glucose; metab: renally excreted unchanged (dose adj for renal probs); contraindications: none; adverse effects: GI; benefits: weight neutral, no hypoglycemia
glimeperide: what is it, brand name
aka Amaryl, a sulfonyurea
bolus insulin types (3) and peak times
rapid: Aspart, Lipro (1 hr to peak); short-acting: regular (2-4 hrs to peak -> complexed w/ zinc)
basal insulin types (3) and dosing
intermediate: NPH (once or twice/day); long acting: glargine (once/day), detemir (once or twice/day)
rapid-acting insulin: names (3), kinetics (peak, onset, duration), vs. regular (2)
Aspart, Lispro, Glulisine; 1 hr peak (base substitutions disrupt monomer-monomer interactions and decr hexamer formation), 10-20 mins onset, 3-5 hr duration; 2x faster absorption and 2x higher peak concentration
NPH: what is it, duration, dosage, onset, peak
suspension of zinc insulin w/ protamine (positively charged peptide); 10-20 hrs duration; dosed once/twice daily; 1-2 hr onset, 4-8 hrs peak
glargine: what is it, dosage, onset
human analog insulin w/ base substitutions that cause it to exist at pH 4.0 -> when injected it forms microprecipate below skin that takes time to absorb (long lasting); dosed once daily; 1-2 hr onset (flat course)
detemir: what is it, dosage, duration, onset
insulin analog that is acylated w/ myristic acid (remains in solution after injection -> binds to albumin and slowly releases); dosed once or twice daily; duration is dose dependent (up to 24 hrs); .8-2 hr onset (flat course)
regular insulin kinetics (onset, peak, duration)
30-60 mins (complexed w/ zinc) onset, 2-4 hr peak, 6-10 hr duration
PARP inhibitors (olaparib)
used in BRCA1/2 mutation carriers to prevent ss break repair -> “two hit” hypothesis; tumors may restore BRCA1/2 function and thus become resistant to PARP inhibitors and cisplatin (but not taxane now!)
medical tx of impotence: what is it, how does it work, examples (3)
PDE5 inhibitors: sildenafil (Viagra) is prototype -> also vardenafil (Levitra) and tadalafil (Cialis); works by inhibiting breakdown of cGMP by PDE 5, thus incr cGMP and relaxing arteries/trabeculae smooth muscles; works to maintain vasodilatory response (cannot cause it)
PDE5 inhibitors pharmacokinetics: onset, metabolism, distribution, changes in metabolism due to… (4)
work quickly (peak plasma 30-90 mins after oral dose); metabolized by CYP3A4 to active metabolite (accounts for 20% activity); widely distributed throughout body tissues; incr. plasma levels (-> hypotension) in elderly (40% incr), liver disease (80%), severe renal disease (100%), w/ CYP3A4 inhibitors (100% incr -> macrolide antibiotics, antifungals, protease inhibitors, cimetidine - OOC for heartburn)
PDE5 inhibitors indications (4)
current: impotence, primary pulmonary hypertension; future: CF, BPH
PDE5 inhibitors side effects
PDE5 inhibitors prevent breakdown of cGMP, and cGMP is in several other pathways: sperm motility, test synthesis, vaginal smooth muscle, esophageal motility, retinal color vision, inhibition of platelet aggregation; side effects can be divided into four groups: vasodilation (headahce, flushing, rhinitis), CV (hypotension, tachycardia, platelet inhibition), GI (reflux), visual changes (blue green tinged vision, incr. light perception, blurred vision)
tx of female sexual dysfn (6)
educational: behavioral/sex therapy, anatomy arousal and response; HRT (estrogen, sometimes testosterone); vascular tx: PDE5 inhibitors (for SSRI induced dysfn only), Eros therapy (handheld device to incr clitoral blood flow), L-arginine tropical tx (Vigael, Sensua -> substrate for NO synthesis)
mifepristone
used for abortion up to 63 days (approved for 49 days); anti-progestin; take 4-6 hrs to complete abortion (needs 2 visits) * i think its approved longer now, up to ~10 weeks (70 d)
misoprostol
prostaglandin E1 analog (stimulates uterine contractions, softens/primes cervix); FDA approved for prevention and tx of gastric/duodenal ulcers; benefits: heat stable (no refrig), inexpensive, widely available; side effects: flu-like sx (diarrhea, nausea, vomiting, headaches); given vaginally or buccally
methotrexate
anti-folate (used off label for abortion - given IV); takes 3-45 days to complete abortion; slightly less effective than mifepristone (90-95% vs 93-98%); used where mifepristone isn’t approved and to end ectopic pregnancies (vs mifepristone, which only ends uterine pregnancies)
dosing of LT4
start: if under age 60 w/o cardiac disease -> 50-100 mcg, if over 60 or w/ cardiac disease -> 25 mcg; avg final dose (for pts w/o thyroid) = 1.6 mcg/kg PO qd (lower in elderly); give 75% of oral dose if given IV
methimazole: half life, dosing, protein bound? how long to see effects? side effects
half life 4-6 hrs (need 1x daily); starting does 10-30 mg QD; 2-4 weeks for improvement w/ 6-12 weeks to euthyroid; freq of side effects is dose related and there are fewer side effects than PTU; rare teratogenic effects -> use instead of PTU unless in pregnancy or thyroid storm
PTU: half life, dosing, protein bound? how long to see effects? side effects
half life 1 hr (need 3x daily); starting dose 100 mg TID; 2-4 weeks for improvement w/ 6-12 weeks to euthyroid; worse side effects than methimazole (i.e. severe hepatitis only seen w/ PTU) and no dose relationship of side effects; not teratogenic -> use only in pregnancy
when to use PTU
use methimazole in all Grave’s except: first trimester pregnancy, thyroid storm, adverse rxn to methimazole
side effects of antithyroid drugs (5)
most important side effect = agranulocytosis -> rare (.1-.5%) but severe -> can kill and can appear at any dose; severe hepatitis (PTU only at .1%, hence we don’t use it); cholestasis (not as severe as PTU hepatitis, seen w/ methimazole rarely); vasculitis (rare), severe polyarthritis (rare)
special instructions with antithyroid drugs
agranulocytosis is dangerous side effect, so tell pts to stop drug and check WBC for fever or sore throat; if granulocytes <500, hospitalize and give broad spectrum antibiotics, if not, resume drug
amiodarone
anti-arrhytmia drug w/ 37% weight iodine -> can cause hypothyroidism due to Wolf-Chakoff effect, or hyperthryoidism: type 1 due to Jod-Basedow phenomenon in pts w/ underlying thyroid nodular or Graves’ disease, type 2 due to toxic effect of amiodarone causing destructive thyroiditis in normal thyroids causing T3/4 release
raloxifene
type III SERM; competes with E2; acts as estrogen in bone and CVS but anti-estrogen in breast and uterus
type III SERM
raloxifene; competes with E2; acts as estrogen in bone and CVS but anti-estrogen in breast and uterus
tamoxifen
type IV SERM; competes with E2; acts as estrogen in bone, CVS, uterus, but anti-estrogen in breast
type IV SERM
tamoxifen; competes with E2; acts as estrogen in bone, CVS, uterus, but anti-estrogen in breast
RU-486 is what antagonist type?
type II antagonist
Equilin
ERT
Mestranol
estrogen -> inhibit lactation